LENZ Therapeutics, Inc.

Historical 13F Holders

Symbol
LENZ
CUSIP
52635N103
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 52635N103 since 12/18/2024, largest first.

Filer % of Class Filed
BML Investment Partners, L.P. 13G 6.7% 11/4/2026
Event 11/2/2026
BlackRock, Inc. 13G 5.8% 4/27/2026
Event 3/31/2026
BlackRock Portfolio Management LLC 13G 5.2% 10/27/2026
Event 9/30/2026
Squarepoint Ops LLC 13G
5.1% 4/8/2026
Event 4/1/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (7)
Point72 Asset Management, L.P. 13G/A
4.8% 11/14/2025
Event 9/30/2025
Paradigm Biocapital Advisors LP 13G/A
3.8% 11/14/2025
Event 9/30/2025
Millennium Management LLC 13G/A
3.7% 10/21/2026
Event 9/30/2026
Versant Venture Capital VI, L.P. 13D/A
3.4% 11/10/2025
Event 11/5/2025
FMR LLC 13G/A
2.0% 11/5/2026
Event 9/30/2026
RA Capital Management, L.P. 13D/A
0.2% 11/2/2026
Event 10/29/2026
Ridgeback Capital Investments L.P. 13G/A
0% 2/17/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 139 30.6 M $118M
2026 Q2 148 34.7 M $197M
2026 Q1 149 33.1 M $303M
2025 Q4 164 35.1 M $562M
2025 Q3 166 29.1 M $1.36B
2025 Q2 117 24.7 M $725M
2025 Q1 106 21.1 M $542M
2024 Q4 96 19.9 M $572M
2024 Q3 79 18.7 M $445M
2024 Q2 66 18.9 M $327M
2024 Q1 57 16.2 M $362M